The FDA (Food and Drug Administration) just approved a first in its class new cancer drug for acute myeloid leukemia (AML). The new drug, called, called Tibsovo, is manufactured by Agios Pharmaceuticals. Tibsovo is a once-daily pill that might replace chemotherapy for some people with  relapsing AML, a type of…...